Parent Council

The BU Hillel Parent Council advises Hillel staff on student and family concerns as issues arise throughout the academic year and serves as a liaison cohort to the BU Hillel Board of Directors. The group meets three times per year (at the end of the fall and spring semesters and at the end of the summer) and advises the BU Hillel leadership on serving Jewish students on campus. Contact Ethan Sobel ( to consider joining.

(grad year of child)

Camille Nelson Kotton (MD, FIDSA, FAST), Council Chair,  is the BU Hillel Parent Council Chair and mother of David Kotton ’25 (and Ben Kotton, Yale, ’24).  She grew up in Massachusetts and graduated from Wesleyan University with a combined major in biochemistry and French literature, then from University of Chicago school of medicine.  She is a member of Temple Emanuel in Newton Massachusetts. She is the clinical director of the Transplant and Immunocompromised Host Infectious Diseases Program in the Infectious Diseases Division at Massachusetts General Hospital, and an associate professor of medicine at Harvard Medical School in Boston, MA.  She is a member of the CDC Advisory Committee on Immunization Practices (ACIP) and is involved in national decisions regarding COVID-19 and other vaccines.  During the COVID-19 pandemic she served on multiple medical panels to keep local synagogues and Jewish day schools open, healthy, and thriving.


Susan Shiff, PhD, MBA, is President/CEO of Ontada and mother of Lex Shiff ’27 . Previoulsy, she was a Senior Vice President at Merch & Co, and the architect and Head of the Center for Observational and Real-World Evidence (CORE).  Dr. Shiff has over 20 years of experience in the pharmaceutical industry as
leader in the development and implementation of evidence, access, and pricing strategies for
products globally. Dr. Shiff began her career at the Centers for Disease Control and Prevention
and has held senior positions at Teva, Pfizer, and Roche. She holds an MBA from Cornell
University and a PhD from the University of California at Los Angeles. Dr. Shiff currently serves
on the Boards of Cara Theraputics, Synthace Limited, and the New Jersey Symphony. In 2016,
she was selected as one of FiercePharma’s Top 15 Women in Biopharma, in 2017 Proclinical
named her as one of today's most inspiring women in the pharmaceutical industry, and in 2018
CB Insights named CORE as one of the most innovative Corporate Labs in healthcare.

  • Mindy Berger ’25 (MD)
  • Ernest and Paula Fraenkel ’25 (MA)
  • Joshua Friedman ’24 (PA)
  • Andre and Jacqui Kaplan ’25 (NY)
  • Steven and Rachel Klein ’24 (PA)
  • Carol Lean ’25 (CA)
  • Robin Lenkin ’25 (MD)
  • Mark Levine ’24 (TX)
  • Larry Shiff ’27 (NJ)
  • Melanie Susswein’2025 (TX)
  • Judy Usow ’24 (MA)